Leone, Armand

Anuj Wadhwa is an associate at Rakoczy Molino Mazzochi Siwik LLP. He is registered to practice before the United States Patent and Trademark Office, and holds a degree in biochemistry.

Litigation

Mr. Wadhwa has extensive experience in all aspects of litigation, including pre-filing investigations, discovery, motion practice, Markman hearings, and pre-trial and trial practice. He has conducted and defended depositions, drafted and argued motions, prepared witnesses and experts, and appeared in court for status and motion hearings. His work encompasses a wide variety of pharmaceutical patents and technologies, and he is involved in all areas of the firm's patent litigation practice.

Opinion Writing, Patent Prosecution, and Legal Counseling

Mr. Wadhwa also is involved in the firm's patent counseling work. He has drafted numerous opinions of counsel, including non-infringement, invalidity, right-to-make and freedom to operate opinions. Mr. Wadhwa regularly assists clients in making patentability assessments, evaluating competitive patent portfolios, and conducting prior art searches. He also has extensive experience in counseling clients with respect to their patent portfolio strategies, and preparing and prosecuting patent applications.

Mr. Wadhwa has experience with various technological fields, including pharmaceutical compositions, DNA sequencing, protein synthesis, neocartilage, polymer chemistry, organic and inorganic chemistry, medical devices, chemical packaging, food products, nutritional supplements, mechanical systems, gypsum panels, lighting assemblies, electroluminescent compounds, sporting goods equipment, Internet authentication systems, business methods, and software systems.

Previous Experience

Prior to joining RMMS, Mr. Wadhwa previously was an associate at Greer, Burns & Crain, Ltd. Prior to attending law school, he worked as a laboratory assistant for Milette, Vander Wood & Associates, where he conducted laboratory research for pharmaceutical companies to determine compliance with FDA regulations for experimental drugs and devices.